GT
Glenmede Trust Portfolio holdings
AUM
$18.6B
1-Year Return
8.78%
This Quarter Return
+1.69%
1 Year Return
+8.78%
3 Year Return
+33.81%
5 Year Return
+160.7%
10 Year Return
+249.02%
AUM
$19.6B
AUM Growth
-$1.32B
(-6.3%)
Cap. Flow
-$1.38B
Cap. Flow
% of AUM
-7.05%
Top 10 Holdings %
Top 10 Hldgs %
25.07%
Holding
1,468
New
83
Increased
502
Reduced
673
Closed
84
Top Buys
| 1 |
iShares Russell 2500 ETF
SMMD
|
$96.4M |
| 2 |
Putnam Focused Large Cap Value ETF
PVAL
|
$63.8M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
$46.6M |
| 4 |
Lam Research
LRCX
|
$37M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$22M |
Top Sells
| 1 |
Apple
AAPL
|
$119M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
$74.9M |
| 3 |
Microsoft
MSFT
|
$64.6M |
| 4 |
Merck
MRK
|
$59.5M |
| 5 |
Home Depot
HD
|
$40.2M |
Sector Composition
| 1 | Technology | 23.77% |
| 2 | Financials | 10.7% |
| 3 | Healthcare | 9.86% |
| 4 | Consumer Discretionary | 9.05% |
| 5 | Industrials | 6.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Intel
INTC
$106B
| $30.3M | 0.15% |
1,512,410
+343,723
| +29% | +$6.89M |
|
127
Intercontinental Exchange
ICE
$100B
| $30M | 0.15% |
201,453
+1,792
| +0.9% | +$267K |
|
128
Eaton
ETN
$135B
| $29.9M | 0.15% |
90,077
+3,506
| +4% | +$1.16M |
|
129
Air Products & Chemicals
APD
$63.9B
| $29.6M | 0.15% |
102,071
-10,208
| -9% | -$2.96M |
|
130
TE Connectivity
TEL
$61.1B
| $29.2M | 0.15% |
203,894
+9,630
| +5% | +$1.38M |
|
131
Intuitive Surgical
ISRG
$161B
| $28.6M | 0.15% |
54,735
+1,170
| +2% | +$611K |
|
132
United Parcel Service
UPS
$71.1B
| $28.5M | 0.15% |
226,037
-118,572
| -34% | -$15M |
|
133
IBM
IBM
$229B
| $27.8M | 0.14% |
126,609
-43,668
| -26% | -$9.6M |
|
134
US Bancorp
USB
$75.9B
| $27.7M | 0.14% |
578,493
-66,815
| -10% | -$3.2M |
|
135
Bank of New York Mellon
BK
$74.4B
| $27.7M | 0.14% |
360,058
-38,874
| -10% | -$2.99M |
|
136
Becton Dickinson
BDX
$54.2B
| $26.8M | 0.14% |
118,027
-1,784
| -1% | -$405K |
|
137
Zoetis
ZTS
$67.4B
| $26.4M | 0.13% |
162,085
+13,798
| +9% | +$2.25M |
|
|
138
Regeneron Pharmaceuticals
REGN
$60.6B
| $26.4M | 0.13% |
37,010
+30,915
| +507% | +$22M |
|
139
Philip Morris
PM
$253B
| $26.3M | 0.13% |
218,798
-20,661
| -9% | -$2.49M |
|
140
Hewlett Packard
HPE
$31.7B
| $26.3M | 0.13% |
1,232,940
-164,569
| -12% | -$3.51M |
|
141
Axalta
AXTA
$6.69B
| $26.3M | 0.13% |
768,074
+13,535
| +2% | +$463K |
|
142
Western Alliance Bancorporation
WAL
$10B
| $25.8M | 0.13% |
309,343
-2,643
| -0.8% | -$221K |
|
143
Edwards Lifesciences
EW
$47.7B
| $25.8M | 0.13% |
349,050
-32,118
| -8% | -$2.38M |
|
144
Expedia Group
EXPE
$26.4B
| $25.7M | 0.13% |
137,699
+3,293
| +2% | +$614K |
|
145
Novo Nordisk
NVO
$250B
| $25.6M | 0.13% |
297,592
+2,162
| +0.7% | +$186K |
|
146
Stryker
SYK
$151B
| $24.9M | 0.13% |
69,030
+880
| +1% | +$317K |
|
147
Oneok
OKE
$46.5B
| $24.8M | 0.13% |
246,865
-55,080
| -18% | -$5.53M |
|
148
Baker Hughes
BKR
$45.5B
| $24.8M | 0.13% |
604,191
-49,854
| -8% | -$2.05M |
|
149
Target
TGT
$42.1B
| $24.6M | 0.13% |
181,897
-7,627
| -4% | -$1.03M |
|
150
Gilead Sciences
GILD
$141B
| $24.3M | 0.12% |
263,376
-28,672
| -10% | -$2.65M |
|